Scopine as a novel brain-targeting moiety enhances the brain uptake of chlorambucil
…, Y Li, T Gong, X Sun, Y Fu, Q He, Z Zhang
Index: Xuan, Zhang; Xing, Liu; Tao, Gong; Xun, Sun; Zhang, Zhi-Rong Acta Pharmacologica Sinica, 2012 , vol. 33, # 2 p. 279 - 288
Full Text: HTML
Citation Number: 4
Abstract
The blood brain barrier (BBB) represents the biggest challenge for therapeutic drugs to enter the brain. In our study, we selected chlorambucil (CHL), an alkylating agent, as the model therapeutic agent, and used scopine as a novel brain-targeting moiety. Here, we
Related Articles:
N-heterocyclic carbene-catalyzed amidation of unactivated esters with amino alcohols
[Movassaghi, Mohammad; Schmidt, Michael A. Organic Letters, 2005 , vol. 7, # 12 p. 2453 - 2456]
[Qiu, Renhua; Zhang, Guoping; Ren, Xiaofang; Xu, Xinhua; Yang, Ronghua; Luo, Shenglian; Yin, Shuangfeng Journal of Organometallic Chemistry, 2010 , vol. 695, # 8 p. 1182 - 1188]
[Brahmachari, Goutam; Laskar, Sujay; Sarkar, Sajal Journal of Chemical Research, 2010 , # 5 p. 288 - 295]
N-heterocyclic carbene-catalyzed amidation of unactivated esters with amino alcohols
[Movassaghi, Mohammad; Schmidt, Michael A. Organic Letters, 2005 , vol. 7, # 12 p. 2453 - 2456]
A linear Brönsted??type behavior in the aminolysis of substituted naphthyl acetates
[International Journal of Chemical Kinetics, , vol. 33, # 3 p. 157 - 164]